The antiviral drug valaciclovir (Valtrex), given prophylactically, kept patients with systemic lupus erythematosus (SLE) ...
Controlling cardiovascular risk factors and maintaining long-term disease remission mitigated the increased risk for ...
“Living alone, I rely on my parents and friends to help with daily tasks during flares,” she shares. “This experience has ...
For the first time, Selena Gomez is being recognized by the Golden Globes for her work in film. The actress has been ...
New research shows nightmares and hallucinations may predict autoimmune flares. Learn how these overlooked symptoms could ...
"Incomplete lupus" is a term used to describe a person who has some symptoms of lupus but not enough to make the diagnosis ...
The prevalence of fibromyalgia is higher among patients with SLE vs the general population, adding to an already significant ...
CAR-T cell therapy, a marvel of bioengineering, takes a patient’s own immune cells and reprograms them to attack cells causing Lupus. First approved for treating leukemia in 2017, CAR-T cell therapy ...
CCAR-168 is under clinical development by AbelZeta and currently in Phase I for Lupus Nephritis. According to GlobalData, Phase I drugs for Lupus Nephritis have an 84% phase transition success rate ...